These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21062648)

  • 21. [PSA based screening for prostatic cancer].
    Johansen TE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate cancer: a review of common underwriting problems, Part 1.
    Richie RC; Swanson JO
    J Insur Med; 2004; 36(3):242-54. PubMed ID: 15495440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
    Schröder FH; Bangma CH; Roobol MJ
    Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on screening for prostate cancer with prostate-specific antigen.
    Schmid HP; Riesen W; Prikler L
    Crit Rev Oncol Hematol; 2004 Apr; 50(1):71-8. PubMed ID: 15094160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
    Raaijmakers R; de Vries SH; Blijenberg BG; Wildhagen MF; Postma R; Bangma CH; Darte C; Schröder FH
    Eur Urol; 2007 Nov; 52(5):1358-64. PubMed ID: 17499425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Based on current knowledge the introduction of the PSA screening for prostatic cancer is unethical].
    Krantz I; Sachs L; Ahlberg BM; Nordin P; Nilstun T
    Lakartidningen; 2005 Sep 5-11; 102(36):2498-500. PubMed ID: 16196436
    [No Abstract]   [Full Text] [Related]  

  • 28. The cautionary tale of PSA testing.
    Hoffman RM; Zeliadt SB
    Arch Intern Med; 2010 Jul; 170(14):1262-3. PubMed ID: 20660847
    [No Abstract]   [Full Text] [Related]  

  • 29. What's new in prostate cancer screening and prevention?
    Klein EA
    Cleve Clin J Med; 2009 Aug; 76(8):439-45. PubMed ID: 19652036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PSA screening: the bottom line.
    Elhilali MM
    CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
    [No Abstract]   [Full Text] [Related]  

  • 31. ERSPC, PLCO studies and critique of cochrane review 2013.
    Schröder FH
    Recent Results Cancer Res; 2014; 202():59-63. PubMed ID: 24531778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer detection: beware of the low PSA.
    Haas GP
    Can J Urol; 2007 Jun; 14(3):3534. PubMed ID: 17594742
    [No Abstract]   [Full Text] [Related]  

  • 33. AUA issues a policy report on PSA monitoring. The American Urological Association.
    Scott Morey S
    Am Fam Physician; 2000 Aug; 62(4):883-4. PubMed ID: 10969861
    [No Abstract]   [Full Text] [Related]  

  • 34. [The prostate specific antigen: what can we learn from the American experience?].
    Zhao XJ
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3313-5. PubMed ID: 16409833
    [No Abstract]   [Full Text] [Related]  

  • 35. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 36. [Early detection of cancer of the prostate. Pros and cons].
    Hoesl CE; Altwein JE
    MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PSA Conundrum.
    Barry MJ
    Arch Intern Med; 2006 Jan; 166(1):7-8. PubMed ID: 16401804
    [No Abstract]   [Full Text] [Related]  

  • 38. [The PSA test does not hold for screening. Good--but not good enough].
    Holmström B; Johansson M; Bratt O; Stattin P
    Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
    [No Abstract]   [Full Text] [Related]  

  • 39. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O; Damber JE; Kärvinge C; Malm T; Hensjö LO; Hyttsten E
    Lakartidningen; 2008 Feb 20-26; 105(8):524-8. PubMed ID: 18363292
    [No Abstract]   [Full Text] [Related]  

  • 40. [PSA test inconvenience?].
    Drøsdal HH
    Tidsskr Nor Laegeforen; 2005 Mar; 125(5):623; author reply 623. PubMed ID: 15776048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.